Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Five-Year Survival in EGFR-Mutant Metastatic Lung Adenocarcinoma Treated with EGFR-TKIs.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: November 16, 2015
Cost-effectiveness of multiplexed predictive biomarker screening in non-small-cell lung cancer.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: January 16, 2015
Interstitial lung abnormalities in treatment-naïve advanced non-small-cell lung cancer patients are associated with shorter survival.
Journal: European journal of radiology
Published: September 26, 2014
The impact of genomic changes on treatment of lung cancer.
Journal: American journal of respiratory and critical care medicine
Published: July 12, 2013
Clinical, pathologic, and biologic features associated with BRAF mutations in non-small cell lung cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 09, 2013
RECIST 1.1 in NSCLC patients with EGFR mutations treated with EGFR tyrosine kinase inhibitors: comparison with RECIST 1.0.
Journal: AJR. American journal of roentgenology
Published: June 25, 2013
Tumor volume decrease at 8 weeks is associated with longer survival in EGFR-mutant advanced non-small-cell lung cancer patients treated with EGFR TKI.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: June 22, 2013
Meta-analysis of EGFR kinase inhibitors: not always greater than the sum of its parts.
Journal: Journal of the National Cancer Institute
Published: April 19, 2013
The introduction of systematic genomic testing for patients with non-small-cell lung cancer.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: November 17, 2012
Radiographic assessment and therapeutic decisions at RECIST progression in EGFR-mutant NSCLC treated with EGFR tyrosine kinase inhibitors.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: August 23, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026